In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres

被引:35
作者
Faranesh, AZ
Nastley, MT
de la Cruz, CP
Haller, MF
Laquerriere, P
Leong, KW
McVeigh, ER
机构
[1] NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA
[2] NIH, Supramol Struct & Funct Resource, Off Res Serv, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA
关键词
gadolinium; vascular endothelial growth factor; contrast media; drug delivery;
D O I
10.1002/mrm.20092
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL-lactic-co-glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). The microspheres were characterized in terms of size, drug and contrast agent encapsulation, and degradation rate. The PLGA microspheres had a mean diameter of 48 +/- 18 mum. The gadolinium loading was 17 +/- 3 mug/mg polymer and the VEGF loading was 163 +/- 22 ng/mg polymer. Electron microscopy revealed that the Gd was dispersed throughout the microspheres and it was confirmed that the Gd loading was sufficient to visualize the microspheres under MRI. VEGF and Gd-DTPA were released from the microspheres in vitro over a period of similar to6 weeks in three phases: a burst, followed by a slow steady-state, then a rapid steady-state. Biodegradable Gd-doped microspheres can be effectively used to deliver drugs in a sustained manner, while being monitored noninvasively with MRI. Published 2004 Wiley-Liss, Inc.
引用
收藏
页码:1265 / 1271
页数:7
相关论文
共 29 条
[1]
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers [J].
Athanasiou, KA ;
Niederauer, GG ;
Agrawal, CM .
BIOMATERIALS, 1996, 17 (02) :93-102
[2]
Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[3]
Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis [J].
Cleland, JL ;
Duenas, ET ;
Park, A ;
Daugherty, A ;
Kahn, J ;
Kowalski, J ;
Cuthbertson, A .
JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) :13-24
[4]
The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Cleland, JL ;
Mac, A ;
Boyd, B ;
Yang, J ;
Duenas, ET ;
Yeung, D ;
Brooks, D ;
Hsu, C ;
Chu, H ;
Mukku, V ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :420-425
[5]
CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[6]
A COMPARISON OF ONE-SHOT AND RECOVERY METHODS IN T1-IMAGING [J].
CRAWLEY, AP ;
HENKELMAN, RM .
MAGNETIC RESONANCE IN MEDICINE, 1988, 7 (01) :23-34
[7]
Edmundson I C, 1967, Adv Pharm Sci, V2, P95
[8]
GADOLINIUM-DTPA AS A CONTRAST AGENT IN MR IMAGING - THEORETICAL PROJECTIONS AND PRACTICAL OBSERVATIONS [J].
GADIAN, DG ;
PAYNE, JA ;
BRYANT, DJ ;
YOUNG, IR ;
CARR, DH ;
BYDDER, GM .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1985, 9 (02) :242-251
[9]
Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis [J].
Hershey, JC ;
Baskin, EP ;
Glass, JD ;
Hartman, HA ;
Gilberto, DB ;
Rogers, IT ;
Cook, JJ .
CARDIOVASCULAR RESEARCH, 2001, 49 (03) :618-625
[10]
Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia [J].
Hopkins, SP ;
Bulgrin, JP ;
Sims, RL ;
Bowman, B ;
Donovan, DL ;
Schmidt, SP .
JOURNAL OF VASCULAR SURGERY, 1998, 27 (05) :886-895